KHN’s ‘What the Health?’: We May Be Done With Covid, But Covid’s Not Done With Us

The White House makes a move as a new wave of covid threatens. President Joe Biden brings in Dr. Ashish Jha to take over the executive branch effort. Meanwhile, it remains unclear if and when Congress can come up with the funds to continue much of the federal anti-covid effort. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sandhya Raman of CQ Roll Call, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more.

It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.

At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.

‘American Diagnosis’: A Fuller Moon Rising — Revised ‘Violence Against Women Act’ Offers Hope

The Violence Against Women Act (VAWA) was reauthorized on March 10, 2022, reaffirming tribes’ authority to prosecute non-Native perpetrators of sexual violence and certain other crimes. This episode looks at the history of VAWA, and how protections for Native women have been tangled in the fine print of the law.

Want Vulnerable Californians to Have Healthier Pregnancies? Doulas Say the State Must Pay Up.

California was supposed to start paying doulas this year to help Medicaid enrollees have healthy pregnancies. But the benefit has been delayed because doulas feel lowballed by the state’s proposed reimbursement rate, which is below what most other states pay.

KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now

The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Two Years In, Covid Leaves Montana Public Health Officials Feeling ‘Watched’

Montanans engage in plenty of spirited political disagreements. But debates about covid-19, public health, and personal liberties have reached a fever pitch, tugging at tightknit towns and making some residents wonder how their communities will survive.

One California University Has Unified Town and Gown to Fight Covid. Why Haven’t Others?

The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.

Watch: California’s Top Health Adviser on Learning to Live With Covid

KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.

HIV Preventive Care Is Supposed to Be Free in the US. So, Why Are Some Patients Still Paying?

The Department of Labor issued rules in July clarifying that health plans need to cover the costs of prescription drugs proven to prevent HIV infection, along with related lab tests and medical appointments, at no cost to patients. More than half a year later, the erroneous billing continues.